Overview
Emerging research highlights the impact of chronic aflatoxin exposure on vulnerable populations, including those who are immunocompromised, pregnant, or managing chronic conditions. Evidence links exposure to immune suppression, liver dysfunction, and increased disease progression.
Identifying mycotoxin exposure through tools like the MycoTOX Profile can support more informed clinical decision-making and targeted intervention.
You Might Also Like
View All News
Partner Podcast: CEO Scott Mattivi Shares Mosaic Diagnostics’ Vision for the Future of Specialty Diagnostics
In this podcast interview, Dr. Woeller has a conversation with Scott Mattivi, CEO of Mosaic Diagnostics Laboratory (formally Great Plains Laboratory).
Press Release: Mosaic Diagnostics Expands Leadership Team as Functional Medicine Accelerates Globally
OVERLAND PARK, KS, UNITED STATES, September 3, 2025 /EINPresswire.com/ — Mosaic Diagnostics (MosaicDX), a global pioneer in specialty diagnostic testing, is pleased to announce the expansion of its executive leadership team.
MosaicDX is Now Part of the Fullscript Labs Catalog
Mosaic Diagnostics Tests Now Available on Fullscript
We’re excited to announce a new partnership with Fullscript, a leading care delivery platform for integrative and functional medicine practitioners.
Stay Informed, Stay Ahead
Join the MosaicDX community and elevate your testing knowledge.